Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0000897069-26-000224

Pres. Research & Development acquired 49 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young David Pres. Research & Development 2026-01-01 Option exercise +49 8,752 D
Derivatives
Young David Pres. Research & Development 2026-01-01 Option exercise · Restricted Stock Units −49 0 D
Loading xslF345X05/form4.xml…